Walgreens reportedly contacting potential buyers for Boots U.K. pharmacy chainAccording to a report, Walgreens is reportedly working with advisers to conduct preliminary discussions with prospective bidders for the unit, worth about $8.78 billion. Nestlé India, Dr. Reddy’s form joint venture for nutraceuticals in IndiaThe joint venture will help JV Partners grow their complementary nutraceuticals portfolios in various categories. DrFirst acquires Myndshft Technologies The acquisition aims to expedite access to specialty medications. Bayer, Dr. Reddy’s ink deal for second brand of Vericiguat in India Bayer has granted non-exclusive rights to Dr. Reddy’s under the brand name Gantra. Dr. Reddy's Aurigene intros Aurigene.AI Aurigene.AI is an AI and ML-assisted platform for accelerating drug discovery projects from hit identification to candidate nomination. Carenet completes acquisition of Health Dialog assets from Rite Aid Carenet is expanding its existing portfolio with AI-driven platforms from Health Dialog. Simbe partners with Plexus to scale manufacturing, meet global retail demand Plexus is an electronics manufacturing services company specializing in the design, manufacture and service of products and regulatory environments. Dr. Reddy's releases generic Oracea Generic Oracea is indicated for the treatment of inflammatory lesions of rosacea in adult patients. Alvotech to manufacture Humira biosimilar for Quallent Pharmaceuticals The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label. Sandoz reaches agreement with Amgen on denosumab biosimilars The agreement clears the path for the launch of Jubbonti and Wyost on May 31, 2025, or earlier under certain circumstances. First Previous 21 22 23 24 25 Next Last
